価格表

在庫・価格 : 2024年04月20日 23時26分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
FGF-21, Human, ELISA Kit (96 well) <Fibroblast Growth Factor-21, ELISA Kit>
データシート
RD191108200R BLMバイオベンダー ラボラトリー
BioVendor Laboratory Medicine, Inc.
1 kit ¥132,000
(未発注)
追加

在庫・価格 : 2024年04月20日 23時26分 現在

FGF-21, Human, ELISA Kit (96 well) <Fibroblast Growth Factor-21, ELISA Kit>

  • 商品コード:RD191108200R
  • メーカー:BLM
  • 包装:1kit
  • 価格: ¥132,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Zhang X et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008 May;57(5):1246-53
Zhang X et al
2008/01/01
PubMed
2 Dost叩lov叩 I et al. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 2008 Sep;93(9):3627-32
Dost叩lov叩 I et al
2008/01/01
PubMed
3 Stein S et al. Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care 2009 Jan;32(1):126-8
Stein S et al
2009/01/01
PubMed
4 Li H et al. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects. J. Clin. Endocrinol. Metab. 2009 Jun;94(6):2151-6
Li H et al
2009/01/01
PubMed
5 Dost叩lov叩 I et al. Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus. Physiol Res 2009;58(1):1-7
Dost叩lov叩 I et al
2009/01/01
PubMed
6 Dost叩lov叩 I et al. Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Eur. J. Endocrinol. 2009 Sep;161(3):397-404
Dost叩lov叩 I et al
2009/01/01
PubMed
7 Christodoulides C et al. Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. J. Clin. Endocrinol. Metab. 2009 Sep;94(9):3594-601
Christodoulides C et al
2009/01/01
PubMed
8 Stein S et al. Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metab. Clin. Exp. 2010 Jan;59(1):33-7
Stein S et al
2010/01/01
PubMed
9 Mraz M et al. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin. Endocrinol. (Oxf) 2009 Sep;71(3):369-75
Mraz M et al
2009/01/01
PubMed
10 Hojman P et al. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 2009 Dec;58(12):2797-801
Hojman P et al
2009/01/01
PubMed
11 Fazeli PK et al. Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J. Clin. Endocrinol. Metab. 2010 Jan;95(1):369-74
Fazeli PK et al
2010/01/01
PubMed
12 Han SH et al. Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis. Metab. Clin. Exp. 2010 Nov;59(11):1656-62
Han SH et al
2010/01/01
PubMed
13 Fisher FM et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 2010 Nov;59(11):2781-9
Fisher FM et al
2010/01/01
PubMed
14 Ahola S et al. Modified Atkins diet induces subacute selective ragged-red-fiber lysis in mitochondrial myopathy&#xA0;patients. EMBO Mol Med 2016 11;8(11):1234-1247
Ahola S et al
2016/01/01
PubMed
15 Bisgaard A et al. Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents. Int J Pediatr Endocrinol 2014;2014(1):7
Bisgaard A et al
2014/01/01
PubMed
16 Bookout AL et al. FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat. Med. 2013 Sep;19(9):1147-52
Bookout AL et al
2013/01/01
PubMed
17 Chen H et al. A high circulating FGF21 level as a prognostic marker in patients with acute myocardial infarction. Am J Transl Res 2018;10(9):2958-2966
Chen H et al
2018/01/01
PubMed
18 Crooks DR et al. Elevated FGF21 secretion, PGC-1&#x3B1; and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle. Hum. Mol. Genet. 2014 Jan;23(1):24-39
Crooks DR et al
2014/01/01
PubMed
19 Cuevas-Ramos D et al. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels. Eur. J. Endocrinol. 2010 Sep;163(3):469-77
Cuevas-Ramos D et al
2010/01/01
PubMed
20 Cuevas-Ramos D et al. Exercise increases serum fibroblast growth factor 21 (FGF21) levels. PLoS ONE 2012;7(5):e38022
Cuevas-Ramos D et al
2012/01/01
PubMed
21 Fisher FM et al. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. Gastroenterology 2014 Nov;147(5):1073-83.e6
Fisher FM et al
2014/01/01
PubMed
22 Gallego-Escuredo JM et al. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients. Int J Obes (Lond) 2015 Jan;39(1):121-9
Gallego-Escuredo JM et al
2015/01/01
PubMed
23 Gariani K et al. Increased FGF21 plasma levels in humans with sepsis and SIRS. Endocr Connect 2013;2(3):146-53
Gariani K et al
2013/01/01
PubMed
24 Guasti L et al. Elevated FGF21 leads to attenuated postnatal linear growth in preterm infants through GH resistance in chondrocytes. J. Clin. Endocrinol. Metab. 2014 Nov;99(11):E2198-206
Guasti L et al
2014/01/01
PubMed
25 Hero M et al. Serum FGF21 in boys with idiopathic short stature: relationship to lipid profile, onset of puberty and growth. Clin. Endocrinol. (Oxf) 2011 Jul;75(1):141-2
Hero M et al
2011/01/01
PubMed
26 Isaac O et al. [Biochemical studies on camomile components/III. In vitro studies about the antipeptic activity of (--)-alpha-bisabolol (author&quot;s transl)]. Arzneimittelforschung 1975 Sep;25(9):1352-4
Isaac O et al
1975/01/01
PubMed
27 Jian WX et al. Association between serum fibroblast growth factor 21 and diabetic nephropathy. Metab. Clin. Exp. 2012 Jun;61(6):853-9
Jian WX et al
2012/01/01
PubMed
28 Jin QR et al. Correlation of fibroblast growth factor 21 serum levels with metabolic parameters in Japanese subjects. J. Med. Invest. 2014;61(1-2):28-34
Jin QR et al
2014/01/01
PubMed
29 Kohara M et al. Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease. PLoS ONE 2017;12(6):e0178971
Kohara M et al
2017/01/01
PubMed
30 Kotul叩k T et al. Increased circulating and epicardial adipose tissue mRNA expression of fibroblast growth factor-21 after cardiac surgery: possible role in postoperative inflammatory response and insulin resistance. Physiol Res 2011;60(5):757-67
Kotul叩k T et al
2011/01/01
PubMed
31 Kralisch S et al. Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans. J. Endocrinol. 2013 Feb;216(2):135-43
Kralisch S et al
2013/01/01
PubMed
32 Laeger T et al. FGF21 is an endocrine signal of protein restriction. J. Clin. Invest. 2014 Sep;124(9):3913-22
Laeger T et al
2014/01/01
PubMed
33 Lee KJ et al. Expression of Fibroblast Growth Factor 21 and &#x3B2;-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-&#x3BA;B and c-Jun N-Terminal Kinase Pathways. Gut Liver 2018 07;12(4):449-456
Lee KJ et al
2018/01/01
PubMed
34 Lenart-Lipiナгka M et al. Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up. Diabetes Res. Clin. Pract. 2013 Aug;101(2):194-200
Lenart-Lipiナгka M et al
2013/01/01
PubMed
35 Li G et al. FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: The BCAMS Study. Diabetes Metab. 2017 Jun;43(3):253-260
Li G et al
2017/01/01
PubMed
36 Li X et al. Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently. Diabetes Res. Clin. Pract. 2011 Jul;93(1):10-6
Li X et al
2011/01/01
PubMed
37 Lin Z et al. Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile. PLoS ONE 2010 Dec;5(12):e15534
Lin Z et al
2010/01/01
PubMed
38 Lin Z et al. Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese. PLoS ONE 2011 Apr;6(4):e18398
Lin Z et al
2011/01/01
PubMed
39 Liu Y et al. Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury. Sci Rep 2016 08;6:31026
Liu Y et al
2016/01/01
PubMed
40 Mashili FL et al. Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab. Res. Rev. 2011 Mar;27(3):286-97
Mashili FL et al
2011/01/01
PubMed
41 Matuszek B et al. Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes. Endokrynol Pol ;61(1):50-4
Matuszek B et al
PubMed
42 Matsuba I et al. Effects of a novel selective peroxisome proliferator-activated receptor-&#x3B1; modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance. J Diabetes Investig 2018 Nov;9(
Matsuba I et al
2018/01/01
PubMed
43 Miehle K et al. Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy. Cytokine 2016 07;83:239-244
Miehle K et al
2016/01/01
PubMed
44 Moure R et al. Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/&#x3B2;-Klotho System. Antimicrob. Agents Chemother. 2018 06;62(6)
Moure R et al
2018/01/01
PubMed
45 Mutanen A et al. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure. J. Hepatol. 2014 Jan;60(1):183-90
Mutanen A et al
2014/01/01
PubMed
46 Novotny D et al. Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome. Physiol Res 2014;63(2):219-28
Novotny D et al
2014/01/01
PubMed
47 Payne BA et al. Elevated serum fibroblast growth factor 21 levels correlate with immune recovery but not mitochondrial dysfunction in HIV infection. AIDS Res Ther 2013 Nov;10(1):27
Payne BA et al
2013/01/01
PubMed
48 Reinehr T et al. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2015 Aug;100(8):3004-10
Reinehr T et al
2015/01/01
PubMed
49 Reinehr T et al. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. J. Clin. Endocrinol. Metab. 2012 Jun;97(6):2143-50
Reinehr T et al
2012/01/01
PubMed
50 Sabaratnam R et al. Intact regulation of muscle expression and circulating levels of myokines in response to exercise in patients with&#xA0;type 2 diabetes. Physiol Rep 2018 Jun;6(12):e13723
Sabaratnam R et al
2018/01/01
PubMed
51 Samson SL et al. Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. Diabetologia 2011 Dec;54(12):3093-100
Samson SL et al
2011/01/01
PubMed
52 Sarruf DA et al. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes 2010 Jul;59(7):1817-24
Sarruf DA et al
2010/01/01
PubMed
53 Shen J et al. Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers. J Hepatol 2012 Jun;56(6):1363-70
Shen J et al
2012/01/01
PubMed
54 Spolcov叩 A et al. Changes in FGF21 serum concentrations and liver mRNA expression in an experimental model of complete lipodystrophy and insulin-resistant diabetes. Physiol Res 2014;63(4):483-90
Spolcov叩 A et al
2014/01/01
PubMed
55 Stepan H et al. Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia. Cytokine 2013 May;62(2):322-6
Stepan H et al
2013/01/01
PubMed
56 Suomalainen A et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol 2011 Sep;10(9):806-18
Suomalainen A et al
2011/01/01
PubMed
57 Tanimura Y et al. Acute exercise increases fibroblast growth factor 21 in metabolic organs and circulation. Physiol Rep 2016 Jun;4(12)
Tanimura Y et al
2016/01/01
PubMed
58 Tyynismaa H et al. Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins. J Clin Endocrinol Metab 2011 Feb;96(2):E351-5
Tyynismaa H et al
2011/01/01
PubMed
59 Vienberg SG et al. Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls. Eur J Endocrinol 2012 Jul;167(1):49-57
Vienberg SG et al
2012/01/01
PubMed
60 Vienberg SG et al. Increased glucose-stimulated FGF21 response to oral glucose in obese nondiabetic subjects after Roux-en-Y gastric bypass. Clin Endocrinol (Oxf) 2017 Jan;86(1):156-159
Vienberg SG et al
2017/01/01
PubMed
61 von Holstein-Rathlou S et al. FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver. Cell Metab. 2016 Feb;23(2):335-43
von Holstein-Rathlou S et al
2016/01/01
PubMed
62 BonDurant LD et al. FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms. Cell Metab. 2017 Apr;25(4):935-944.e4
BonDurant LD et al
2017/01/01
PubMed
63 Kirmse B et al. Plasma fibroblast growth factor-21 levels in patients with inborn errors of metabolism. Mol Genet Metab Rep 2017 Dec;13:52-54
Kirmse B et al
2017/01/01
PubMed
64 Morovat A et al. Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice. J Clin Med 2017 Aug;6(8)
Morovat A et al
2017/01/01
PubMed
65 Samms RJ et al. FGF21 Is an Insulin-Dependent Postprandial Hormone in Adult Humans. J Clin Endocrinol Metab 2017 Oct;102(10):3806-3813
Samms RJ et al
2017/01/01
PubMed
66 Sepp辰 S et al. Fibroblast Growth Factor 21, Adiponectin, and Irisin as Markers of Unfavorable Metabolic Features in 12-Year-Old Children. J Endocr Soc 2019 Apr;3(4):825-837
Sepp辰 S et al
2019/01/01
PubMed
67 Laeger T et al. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes. Diabetologia 2017 Nov;60(11):2274-2284
Laeger T et al
2017/01/01
PubMed
68 Mai K et al. Immunological Alterations due to Hemodialysis Might Interfere with Early Complications in Renal Transplantation. Anal Cell Pathol (Amst) 2019;2019:8389765
Mai K et al
2019/01/01
PubMed
69 Saeidi A et al. Independent and Combined Effects of Antioxidant Supplementation and Circuit Resistance Training on Selected Adipokines in Postmenopausal Women. Front Physiol 2019;10:484
Saeidi A et al
2019/01/01
PubMed
70 Kl鱈mov叩 J et al. FGF21 Levels in Pheochromocytoma/Functional Paraganglioma. Cancers (Basel) 2019 Apr;11(4)
Kl鱈mov叩 J et al
2019/01/01
PubMed
71 Song P et al. The Hormone FGF21 Stimulates Water Drinking in Response to Ketogenic Diet and Alcohol. Cell Metab. 2018 Jun;27(6):1338-1347.e4
Song P et al
2018/01/01
PubMed
72 Zhang X et al. Erratum. Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans. Diabetes 2008;57:1246-1253. Diabetes 2019 Jan;68(1):235
Zhang X et al
2019/01/01
PubMed
73 Yates MS et al. Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer. Cancer Prev Res (Phila) 2018 Aug;11(8):477-490
Yates MS et al
2018/01/01
PubMed
74 Panera N et al. The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation. EBioMedicine 2021 Mar;65:103249
Panera N et al
2021/01/01
PubMed
75 Motlagh Scholle L et al. Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency. Int J Mol Sci 2019 Mar;20(6)
Motlagh Scholle L et al
2019/01/01
PubMed
76 Pe単as A et al. Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders. Int J Mol Sci 2021 Jun;22(12)
Pe単as A et al
2021/01/01
PubMed
77 Socha-Banasiak A et al. Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters. BMC Pediatr 2020 Jun;20(1):294
Socha-Banasiak A et al
2020/01/01
PubMed
78 Šimják P et al. Changes in plasma concentrations and mRNA expression of hepatokines fetuin A, fetuin B and FGF21 in physiological pregnancy and gestational diabetes mellitus. Physiol Res 2018 Nov;67(Suppl 3):S531-S542
Šimják P et al
2018/01/01
PubMed
79 Kukla M et al. Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course. Biomolecules 2021 Sep;11(10)
Kukla M et al
2021/01/01
PubMed
80 Flippo KH et al. FGF21 signaling in glutamatergic neurons is required for weight loss associated with dietary protein dilution. Sci Rep 2020 Nov;10(1):19521
Flippo KH et al
2020/01/01
PubMed
81 Wang X et al. Comprehensive influence of topological location and neighbor information on identifying influential nodes in complex networks. PLoS One 2021;16(5):e0251208
Wang X et al
2021/01/01
PubMed
82 Campderr坦s L et al. Altered GDF15 and FGF21 Levels in Response to Strenuous Exercise: A Study in Marathon Runners. Front Physiol 2020;11:550102
Campderr坦s L et al
2020/01/01
PubMed
83 Wang C et al. Disruption of FGF Signaling Ameliorates Inflammatory Response in Hepatic Stellate Cells. Front Cell Dev Biol 2020;8:601
Wang C et al
2020/01/01
PubMed
84 Wu G et al. Hypoxia-Induced Adipose Lipolysis Requires Fibroblast Growth Factor 21. Front Pharmacol 2020;11:1279
Wu G et al
2020/01/01
PubMed
85 Urraza-Robledo AI et al. FGF21 serum levels are related to insulin resistance, metabolic changes and obesity in Mexican people living with HIV (PLWH). PLoS One 2021;16(5):e0252144
Urraza-Robledo AI et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Zhang X et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008 May;57(5):1246-53
    Zhang X et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Dost叩lov叩 I et al. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 2008 Sep;93(9):3627-32
    Dost叩lov叩 I et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Stein S et al. Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care 2009 Jan;32(1):126-8
    Stein S et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Li H et al. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects. J. Clin. Endocrinol. Metab. 2009 Jun;94(6):2151-6
    Li H et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Dost叩lov叩 I et al. Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus. Physiol Res 2009;58(1):1-7
    Dost叩lov叩 I et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Dost叩lov叩 I et al. Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Eur. J. Endocrinol. 2009 Sep;161(3):397-404
    Dost叩lov叩 I et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Christodoulides C et al. Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. J. Clin. Endocrinol. Metab. 2009 Sep;94(9):3594-601
    Christodoulides C et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Stein S et al. Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metab. Clin. Exp. 2010 Jan;59(1):33-7
    Stein S et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Mraz M et al. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin. Endocrinol. (Oxf) 2009 Sep;71(3):369-75
    Mraz M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Hojman P et al. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 2009 Dec;58(12):2797-801
    Hojman P et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Fazeli PK et al. Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J. Clin. Endocrinol. Metab. 2010 Jan;95(1):369-74
    Fazeli PK et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Han SH et al. Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis. Metab. Clin. Exp. 2010 Nov;59(11):1656-62
    Han SH et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Fisher FM et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 2010 Nov;59(11):2781-9
    Fisher FM et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Ahola S et al. Modified Atkins diet induces subacute selective ragged-red-fiber lysis in mitochondrial myopathy&#xA0;patients. EMBO Mol Med 2016 11;8(11):1234-1247
    Ahola S et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Bisgaard A et al. Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents. Int J Pediatr Endocrinol 2014;2014(1):7
    Bisgaard A et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Bookout AL et al. FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat. Med. 2013 Sep;19(9):1147-52
    Bookout AL et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Chen H et al. A high circulating FGF21 level as a prognostic marker in patients with acute myocardial infarction. Am J Transl Res 2018;10(9):2958-2966
    Chen H et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Crooks DR et al. Elevated FGF21 secretion, PGC-1&#x3B1; and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle. Hum. Mol. Genet. 2014 Jan;23(1):24-39
    Crooks DR et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Cuevas-Ramos D et al. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels. Eur. J. Endocrinol. 2010 Sep;163(3):469-77
    Cuevas-Ramos D et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Cuevas-Ramos D et al. Exercise increases serum fibroblast growth factor 21 (FGF21) levels. PLoS ONE 2012;7(5):e38022
    Cuevas-Ramos D et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Fisher FM et al. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. Gastroenterology 2014 Nov;147(5):1073-83.e6
    Fisher FM et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Gallego-Escuredo JM et al. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients. Int J Obes (Lond) 2015 Jan;39(1):121-9
    Gallego-Escuredo JM et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Gariani K et al. Increased FGF21 plasma levels in humans with sepsis and SIRS. Endocr Connect 2013;2(3):146-53
    Gariani K et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Guasti L et al. Elevated FGF21 leads to attenuated postnatal linear growth in preterm infants through GH resistance in chondrocytes. J. Clin. Endocrinol. Metab. 2014 Nov;99(11):E2198-206
    Guasti L et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Hero M et al. Serum FGF21 in boys with idiopathic short stature: relationship to lipid profile, onset of puberty and growth. Clin. Endocrinol. (Oxf) 2011 Jul;75(1):141-2
    Hero M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Isaac O et al. [Biochemical studies on camomile components/III. In vitro studies about the antipeptic activity of (--)-alpha-bisabolol (author&quot;s transl)]. Arzneimittelforschung 1975 Sep;25(9):1352-4
    Isaac O et al
    1975/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Jian WX et al. Association between serum fibroblast growth factor 21 and diabetic nephropathy. Metab. Clin. Exp. 2012 Jun;61(6):853-9
    Jian WX et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Jin QR et al. Correlation of fibroblast growth factor 21 serum levels with metabolic parameters in Japanese subjects. J. Med. Invest. 2014;61(1-2):28-34
    Jin QR et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Kohara M et al. Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease. PLoS ONE 2017;12(6):e0178971
    Kohara M et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Kotul叩k T et al. Increased circulating and epicardial adipose tissue mRNA expression of fibroblast growth factor-21 after cardiac surgery: possible role in postoperative inflammatory response and insulin resistance. Physiol Res 2011;60(5):757-67
    Kotul叩k T et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Kralisch S et al. Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans. J. Endocrinol. 2013 Feb;216(2):135-43
    Kralisch S et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Laeger T et al. FGF21 is an endocrine signal of protein restriction. J. Clin. Invest. 2014 Sep;124(9):3913-22
    Laeger T et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Lee KJ et al. Expression of Fibroblast Growth Factor 21 and &#x3B2;-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-&#x3BA;B and c-Jun N-Terminal Kinase Pathways. Gut Liver 2018 07;12(4):449-456
    Lee KJ et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Lenart-Lipiナгka M et al. Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up. Diabetes Res. Clin. Pract. 2013 Aug;101(2):194-200
    Lenart-Lipiナгka M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Li G et al. FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: The BCAMS Study. Diabetes Metab. 2017 Jun;43(3):253-260
    Li G et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Li X et al. Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently. Diabetes Res. Clin. Pract. 2011 Jul;93(1):10-6
    Li X et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Lin Z et al. Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile. PLoS ONE 2010 Dec;5(12):e15534
    Lin Z et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Lin Z et al. Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese. PLoS ONE 2011 Apr;6(4):e18398
    Lin Z et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Liu Y et al. Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury. Sci Rep 2016 08;6:31026
    Liu Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Mashili FL et al. Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab. Res. Rev. 2011 Mar;27(3):286-97
    Mashili FL et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Matuszek B et al. Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes. Endokrynol Pol ;61(1):50-4
    Matuszek B et al
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Matsuba I et al. Effects of a novel selective peroxisome proliferator-activated receptor-&#x3B1; modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance. J Diabetes Investig 2018 Nov;9(
    Matsuba I et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Miehle K et al. Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy. Cytokine 2016 07;83:239-244
    Miehle K et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Moure R et al. Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/&#x3B2;-Klotho System. Antimicrob. Agents Chemother. 2018 06;62(6)
    Moure R et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Mutanen A et al. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure. J. Hepatol. 2014 Jan;60(1):183-90
    Mutanen A et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Novotny D et al. Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome. Physiol Res 2014;63(2):219-28
    Novotny D et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Payne BA et al. Elevated serum fibroblast growth factor 21 levels correlate with immune recovery but not mitochondrial dysfunction in HIV infection. AIDS Res Ther 2013 Nov;10(1):27
    Payne BA et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Reinehr T et al. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2015 Aug;100(8):3004-10
    Reinehr T et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Reinehr T et al. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. J. Clin. Endocrinol. Metab. 2012 Jun;97(6):2143-50
    Reinehr T et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Sabaratnam R et al. Intact regulation of muscle expression and circulating levels of myokines in response to exercise in patients with&#xA0;type 2 diabetes. Physiol Rep 2018 Jun;6(12):e13723
    Sabaratnam R et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Samson SL et al. Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. Diabetologia 2011 Dec;54(12):3093-100
    Samson SL et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Sarruf DA et al. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes 2010 Jul;59(7):1817-24
    Sarruf DA et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Shen J et al. Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers. J Hepatol 2012 Jun;56(6):1363-70
    Shen J et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Spolcov叩 A et al. Changes in FGF21 serum concentrations and liver mRNA expression in an experimental model of complete lipodystrophy and insulin-resistant diabetes. Physiol Res 2014;63(4):483-90
    Spolcov叩 A et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Stepan H et al. Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia. Cytokine 2013 May;62(2):322-6
    Stepan H et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Suomalainen A et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol 2011 Sep;10(9):806-18
    Suomalainen A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Tanimura Y et al. Acute exercise increases fibroblast growth factor 21 in metabolic organs and circulation. Physiol Rep 2016 Jun;4(12)
    Tanimura Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Tyynismaa H et al. Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins. J Clin Endocrinol Metab 2011 Feb;96(2):E351-5
    Tyynismaa H et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Vienberg SG et al. Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls. Eur J Endocrinol 2012 Jul;167(1):49-57
    Vienberg SG et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Vienberg SG et al. Increased glucose-stimulated FGF21 response to oral glucose in obese nondiabetic subjects after Roux-en-Y gastric bypass. Clin Endocrinol (Oxf) 2017 Jan;86(1):156-159
    Vienberg SG et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    von Holstein-Rathlou S et al. FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver. Cell Metab. 2016 Feb;23(2):335-43
    von Holstein-Rathlou S et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    BonDurant LD et al. FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms. Cell Metab. 2017 Apr;25(4):935-944.e4
    BonDurant LD et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Kirmse B et al. Plasma fibroblast growth factor-21 levels in patients with inborn errors of metabolism. Mol Genet Metab Rep 2017 Dec;13:52-54
    Kirmse B et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Morovat A et al. Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice. J Clin Med 2017 Aug;6(8)
    Morovat A et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Samms RJ et al. FGF21 Is an Insulin-Dependent Postprandial Hormone in Adult Humans. J Clin Endocrinol Metab 2017 Oct;102(10):3806-3813
    Samms RJ et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Sepp辰 S et al. Fibroblast Growth Factor 21, Adiponectin, and Irisin as Markers of Unfavorable Metabolic Features in 12-Year-Old Children. J Endocr Soc 2019 Apr;3(4):825-837
    Sepp辰 S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Laeger T et al. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes. Diabetologia 2017 Nov;60(11):2274-2284
    Laeger T et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Mai K et al. Immunological Alterations due to Hemodialysis Might Interfere with Early Complications in Renal Transplantation. Anal Cell Pathol (Amst) 2019;2019:8389765
    Mai K et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Saeidi A et al. Independent and Combined Effects of Antioxidant Supplementation and Circuit Resistance Training on Selected Adipokines in Postmenopausal Women. Front Physiol 2019;10:484
    Saeidi A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Kl鱈mov叩 J et al. FGF21 Levels in Pheochromocytoma/Functional Paraganglioma. Cancers (Basel) 2019 Apr;11(4)
    Kl鱈mov叩 J et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Song P et al. The Hormone FGF21 Stimulates Water Drinking in Response to Ketogenic Diet and Alcohol. Cell Metab. 2018 Jun;27(6):1338-1347.e4
    Song P et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Zhang X et al. Erratum. Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans. Diabetes 2008;57:1246-1253. Diabetes 2019 Jan;68(1):235
    Zhang X et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Yates MS et al. Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer. Cancer Prev Res (Phila) 2018 Aug;11(8):477-490
    Yates MS et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Panera N et al. The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation. EBioMedicine 2021 Mar;65:103249
    Panera N et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Motlagh Scholle L et al. Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency. Int J Mol Sci 2019 Mar;20(6)
    Motlagh Scholle L et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Pe単as A et al. Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders. Int J Mol Sci 2021 Jun;22(12)
    Pe単as A et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Socha-Banasiak A et al. Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters. BMC Pediatr 2020 Jun;20(1):294
    Socha-Banasiak A et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Šimják P et al. Changes in plasma concentrations and mRNA expression of hepatokines fetuin A, fetuin B and FGF21 in physiological pregnancy and gestational diabetes mellitus. Physiol Res 2018 Nov;67(Suppl 3):S531-S542
    Šimják P et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Kukla M et al. Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course. Biomolecules 2021 Sep;11(10)
    Kukla M et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Flippo KH et al. FGF21 signaling in glutamatergic neurons is required for weight loss associated with dietary protein dilution. Sci Rep 2020 Nov;10(1):19521
    Flippo KH et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Wang X et al. Comprehensive influence of topological location and neighbor information on identifying influential nodes in complex networks. PLoS One 2021;16(5):e0251208
    Wang X et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Campderr坦s L et al. Altered GDF15 and FGF21 Levels in Response to Strenuous Exercise: A Study in Marathon Runners. Front Physiol 2020;11:550102
    Campderr坦s L et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Wang C et al. Disruption of FGF Signaling Ameliorates Inflammatory Response in Hepatic Stellate Cells. Front Cell Dev Biol 2020;8:601
    Wang C et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Wu G et al. Hypoxia-Induced Adipose Lipolysis Requires Fibroblast Growth Factor 21. Front Pharmacol 2020;11:1279
    Wu G et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Urraza-Robledo AI et al. FGF21 serum levels are related to insulin resistance, metabolic changes and obesity in Mexican people living with HIV (PLWH). PLoS One 2021;16(5):e0252144
    Urraza-Robledo AI et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed